Search

Your search keyword '"Aversa, F"' showing total 885 results

Search Constraints

Start Over You searched for: Author "Aversa, F" Remove constraint Author: "Aversa, F"
885 results on '"Aversa, F"'

Search Results

208. P.13.7 COMPARISON BETWEEN TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) AND TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION COMBINED WITH PERCUTANEOUS RADIOFREQUENCY ABLATION (TACE-RFA) FOR TREATMENT OF INTERMEDIATE HEPATOCELLULAR CARCINOMA (HCC)

209. P.11.15 IMPACT OF PORTAL VEIN THROMBOSIS ON HEPATOCELLULAR CARCINOMA TREATMENT OUTCOME. THE HEPATOCAT GROUP EXPERIENCE

211. P.18.2 LONG-TERM MAINTENANCE OF SVR IN DIFFICULT-TO-TREAT HCV GENOTYPES IN LIVER TRANSPLANT RECIPIENTS WITH HCV RECURRENCE

212. Effect of ursodeoxycholic acid on hypertransaminasaemia and bile acid composition in patients undergoing bone marrow transplantation--a double-blind randomized control study

213. Measurement of the positron to electron ratio in the cosmic rays above 5 GeV RID G-6769-2011

216. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells

218. 151 REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

219. P.08.13 REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

221. P.08.8 LACK OF RESPONSE AND TUMOR RECURRENCE AFTER MULTIMODAL REPEATED TREATMENT

222. F-23 Lack of response and tumor recurrence after multimodal repeated treatment for hepatocellular carcinoma similarly affect HCC patients survival. A HEPATOCAT group experience

223. F-24 Short treatment with sorafenib is associated to tumor progression in patients with hepatocellular carcinoma

224. Measurement of the positron to electron ration in the cosmic rays above 5 GeV

225. Identification of cosmic ray electrons and positrons by neural network

226. Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin

228. The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma

230. Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study)

233. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

236. Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family

247. Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrow

248. Unrelated donor marrow transplantation for chronic myelogenous leukaemia

Catalog

Books, media, physical & digital resources